Serene Intelligence
Digital employees for healthcare RCM, automating prior auth, eligibility, claims, and appeals.
Website: https://www.chooseserene.com/
Cover Block
Public sources
| Field | Value |
|---|---|
| Name | Serene Intelligence |
| Tagline | Digital employees for healthcare RCM [chooseserene.com] |
| Headquarters | San Jose, CA |
| Founded | 2025 |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Founders | Devan Flores, Christopher Parker [EIN Presswire, 2026] |
Links
Public sources
- Website: https://www.chooseserene.com/
- LinkedIn: https://www.linkedin.com/company/sereneintelligence
Executive Summary
PUBLIC Serene Intelligence is building software that acts as a "digital employee" for healthcare revenue cycle management, with a current focus on prior authorization, eligibility verification, claim status checks, and appeals, a workflow cluster that is operationally painful for providers and still largely manual across payer portals and EHR environments [chooseserene.com, retrieved 2024] [Crunchbase] [EIN Presswire, 2026]. The company merits attention now less because public traction is established, it is not, and more because it is positioning around a narrow, expensive bottleneck in healthcare administration where workflow automation can be adopted before a full system replacement is considered [chooseserene.com, retrieved 2024] [Crunchbase].
The public record is still thin. Serene is listed as founded in 2025, headquartered in San Jose, California, and associated with co-founders Devan Flores and Christopher Parker, although the available sources are limited and one press source appears to assign a CEO title to both names, which leaves team structure only partially corroborated [Crunchbase] [EIN Presswire] [LinkedIn, retrieved 2026].
On product, the company is consistent across its website and third-party profiles: Serene is meant to be added into existing healthcare workflows with logins, permissions, and task delegation, then execute repetitive work inside payer portals and EHR-linked environments while preserving an audit trail for human review [chooseserene.com, retrieved 2024] [Crunchbase] [BeBee, retrieved 2026]. The clearest point of differentiation in the public materials is not model novelty but computer-use automation embedded into the systems provider teams already touch, which lowers the change-management burden if the product performs as advertised [chooseserene.com, retrieved 2024] [BeBee, retrieved 2026].
A small but relevant commercial signal emerged in 2026, when PQT Health announced a partnership to integrate Serene's prior authorization and appeals capabilities into the Dyvine EHR platform, suggesting at least one route to distribution through an existing healthcare software environment [EIN Presswire, 2026] [tennessean.com]. No confirmed funding rounds, investors, or accelerator affiliations appear in the available public record, so the business should be treated as an early SaaS company with financing status still unverified [Crunchbase] [chooseserene.com, retrieved 2024].
Over the next 12 to 18 months, the key watch items are straightforward: whether Serene converts integration language into named deployments, whether it can show measurable cycle-time or denial-management outcomes, and whether the founding team and capitalization become easier to verify through independent reporting rather than company-controlled channels [EIN Presswire, 2026] [chooseserene.com, retrieved 2024] [Crunchbase]. For now, the interest is in the problem selection and workflow thesis; the open question is execution evidence.
Company-stated, unverified -- This section relies materially on company website claims and a company-announced partnership, with partial corroboration from Crunchbase, LinkedIn, and BeBee.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Founding Team | Devan Flores; Christopher Parker |
How the Company Got Here
PUBLIC
Serene Intelligence appears to be a very young healthcare administration software company, with its public footprint centered on a narrow but concrete claim: it builds software that completes repetitive revenue cycle tasks inside the systems provider teams already use [chooseserene.com] [Crunchbase]. Crunchbase lists the company as founded in 2025 and headquartered in San Jose, California, while the company website describes the product as "digital employees for healthcare RCM" that handle prior authorizations, eligibility verification, claim status checks, and appeals across EHRs and payer portals [Crunchbase] [chooseserene.com].
The chronology that can be verified from public materials is still limited, which is typical for a company at this age. The clearest current milestone is product positioning rather than financing or customer disclosure: the homepage lays out an operating model in which customers grant the system logins, permissions, and workflows, then delegate tasks through a dashboard or API, with actions logged for human review [chooseserene.com]. Public source material used here does not establish a legal entity name beyond Serene Intelligence, and no confirmed funding rounds or state filing details were captured in the available record [Crunchbase] [chooseserene.com].
Lightly corroborated -- Based on company website disclosures and a Crunchbase company profile, with no corroborating state filing used in this section.
Product and Technology
MIXED
The product claim is straightforward, even if the evidence base is still thin. Serene Intelligence presents itself as a provider of "digital employees for healthcare RCM," with a workflow focus on prior authorization, eligibility verification, claim status checks, and appeals [chooseserene.com, retrieved 2024]. Crunchbase describes the company in similar terms, saying it develops healthcare workflow automation software that operates within payer portals and electronic health record environments, supporting prior authorizations, insurance appeals and denials, eligibility and benefits verification, and claim status retrieval [Crunchbase]. That alignment matters because it suggests the core positioning is consistent across company and third-party profiles, even though detailed technical documentation is not public.
The website description points to a computer-use automation layer rather than a conventional stand-alone dashboard. According to the homepage, teams can add Serene to existing tools with logins, permissions, and workflows, then delegate tasks from a dashboard or API while the software signs in, navigates EHRs and payer portals, and completes the workflow in the same systems staff already use [chooseserene.com, retrieved 2024]. The same source says every action and outcome is logged for review, implying an audit trail and human oversight model that is especially relevant in reimbursement operations [chooseserene.com, retrieved 2024]. A BeBee advisory-role posting uses similar language, describing Serene as building an AI computer-use system for healthcare that helps provider teams complete prior authorization forms directly inside the portals they already use [BeBee].
A small amount of external validation appears in the Dyvine EHR partnership announcement. EIN Presswire reported in 2026 that Serene's AI prior authorizations and AI appeals and denials capabilities would integrate directly into the Dyvine EHR platform [EIN Presswire, 2026]. PQT Health's LinkedIn language goes further, describing the result as fully autonomous prior authorization workflows and intelligent appeals and denials management within Dyvine EHR, but that remains partner-side promotional language rather than a verified product demo or implementation study [LinkedIn, retrieved 2026]. Public materials do not establish model architecture, accuracy rates, exception handling, deployment timelines, or customer-level performance outcomes.
Company-stated, unverified -- Product scope is corroborated in part by Crunchbase and partner materials, but most functional detail remains company-described and unverified in public technical documentation.
Where the Demand Sits
PUBLIC
The market matters now because U.S. providers are under pressure to move administrative work out of clinician and back-office workflows at the same time that prior authorization scrutiny and revenue-cycle complexity remain high, which creates a credible opening for software that can operate inside existing payer and EHR environments [chooseserene.com, 2024] [Crunchbase].
Public evidence on Serene Intelligence itself is thin, so the market has to be framed through the problems the company says it addresses rather than through a company-specific sizing claim. Serene describes its product as automating prior authorization, eligibility verification, claim status checks, and appeals for healthcare revenue cycle management teams [chooseserene.com, 2024]. Crunchbase characterizes the company similarly, describing software that operates within payer portals and EHR environments for prior authorizations, insurance appeals and denials, eligibility and benefits verification, and claim status retrieval [Crunchbase]. That places Serene in the overlap between healthcare RCM software, prior authorization workflow tools, and a newer category of AI-driven administrative automation for providers.
No named third-party TAM, SAM, or SOM figure was provided in the source set, so any market sizing here would have to rely on analogous markets rather than a directly cited category report. The relevant analogues are provider RCM software and services, prior authorization automation, and broader healthcare administrative workflow software. The common demand signal across those categories is labor intensity: Serene's own pitch centers on replacing hours of portal navigation and form completion with a shorter human review step, and the product design assumes buyers will value automation that works inside incumbent systems rather than requiring a full workflow rip-and-replace [chooseserene.com, 2024]. That is a sensible wedge if the company can prove reliability, because healthcare operations teams usually buy against turnaround time, denial reduction, staffing pressure, and auditability rather than against model novelty.
The nearest adjacent markets are equally important because they shape budget availability and substitution risk. A hospital or medical group could address parts of the same problem through legacy RCM suites, EHR-native workflow modules, outsourced RCM services, or narrower point solutions for eligibility, denials, and prior authorization. Serene's website argues for a different insertion point, adding the product to existing tools with logins, permissions, and workflows, then letting users delegate tasks by dashboard or API while retaining an audit trail for review [chooseserene.com, 2024]. If that workflow holds in production, the company is not only selling into RCM software spend, it is also competing for labor-replacement and outsourcing budgets.
Regulatory and macro conditions also favor administrative automation, though the source set does not include a dedicated policy report and the analysis has to stay narrow. Prior authorization and appeals work are sensitive because they sit close to reimbursement timing and compliance, which means buyers usually need clear logging, human oversight, and system compatibility. Serene explicitly says every action and outcome is logged for review, and its partnership announcement with PQT Health says Serene's AI prior authorization and appeals and denials capabilities are being integrated into the Dyvine EHR platform [chooseserene.com, 2024] [EIN Presswire, 2026]. That combination suggests the practical market question is less whether administrative burden exists, which is widely accepted, and more whether a vendor can clear reliability, security, and workflow-trust hurdles quickly enough to convert that burden into paid deployment.
| Market lens | What public sources support | Why it matters |
|---|---|---|
| Core category | Healthcare RCM workflow automation [chooseserene.com, 2024] [Crunchbase] | Anchors the company in an established provider budget area rather than a purely experimental AI category. |
| High-friction use cases | Prior authorization, eligibility, claim status, appeals [chooseserene.com, 2024] [Crunchbase] | These are repetitive, rules-heavy tasks where manual effort is substantial and ROI can be legible if accuracy is proven. |
| Delivery model | Works across EHRs, payer portals, and internal systems; task delegation via dashboard or API [chooseserene.com, 2024] | Suggests a wedge into existing workflows, which may shorten adoption relative to a full platform replacement. |
| Adjacent spend pools | EHR workflow tools, RCM software, and outsourced admin operations [chooseserene.com, 2024] | Expands the realistic buyer budget beyond a single software line item, but also broadens the competitive set. |
The table points to a market that is easier to justify qualitatively than to size precisely from the available record. The attractive part is clear task pain inside provider reimbursement workflows; the unresolved part is whether Serene is attacking a large software category with budgeted demand or a narrower services substitution opportunity that takes longer to scale.
Company-stated, unverified -- This section relies mainly on company website claims, with partial category corroboration from Crunchbase and one partnership announcement from EIN Presswire.
Competitive Landscape
MIXED Serene Intelligence is positioning itself not as a system of record for healthcare revenue cycle management, but as an automation layer that works inside the EHR and payer portals provider teams already use, which places it closer to workflow software and embedded task automation than to full-suite RCM incumbents [chooseserene.com, retrieved 2024] [Crunchbase, retrieved 2026].
The public record is thin on named rivals, so the competitive map has to start with category boundaries rather than a company-by-company leaderboard. At the incumbent end, the alternatives are established RCM software stacks and service-heavy operating models used by provider organizations to manage prior authorization, eligibility, claim status, denials, and appeals, although no specific incumbent vendors are named in the source set. At the challenger end, Serene presents itself as a "digital employees" product for repetitive reimbursement workflows, with the software logging into payer portals, navigating EHR environments, and leaving an audit trail for human review [chooseserene.com, retrieved 2024] [BeBee, retrieved 2026]. The adjacent substitute is still manual labor: staff working directly in payer portals and internal systems, which the company explicitly describes as the status quo it is trying to compress into a short review step rather than a click-by-click process [chooseserene.com, retrieved 2024].
Serene's clearest edge today appears to be workflow placement, not breadth. The product claims focus on prior authorization, eligibility verification, claim status checks, appeals, and denials, and the company says those tasks can be delegated from a dashboard or API while the software operates in the tools teams already use [chooseserene.com, retrieved 2024] [Crunchbase, retrieved 2026]. The one externally visible distribution signal is the announced partnership with PQT Health to integrate Serene's prior authorization and appeals capabilities into the Dyvine EHR platform, which matters because embedded distribution inside an existing healthcare workflow can shorten adoption friction if the integration is real and production-grade [EIN Presswire, 2026] [LinkedIn, retrieved 2026]. That edge is still perishable. The current evidence does not establish customer scale, proprietary data assets, regulatory clearances, or funding depth, so there is not yet public support for a durable moat beyond execution inside a narrow workflow wedge [chooseserene.com, retrieved 2024] [Crunchbase, retrieved 2026].
The exposure is equally clear: Serene has little publicly verified insulation if better-capitalized workflow vendors, EHR-connected software providers, or RCM platforms decide to build similar portal automation features. Because no named competitors are confirmed in the source set, the immediate threat is best framed as a category risk rather than a single-company risk. If buyers view prior authorization and appeals automation as a feature to be bundled into broader RCM software or into an EHR-adjacent product, a single-purpose automation layer can lose pricing power and channel access quickly. The PQT Health relationship may help on distribution, but it also highlights dependence on partner-controlled channels rather than a clearly demonstrated direct-sales footprint [EIN Presswire, 2026] [tennessean.com].
The most plausible 18-month scenario is a sorting between embedded specialists and broad-suite vendors. The winner if embedded distribution converts into live provider usage is PQT Health, because a functioning Dyvine EHR integration would give its platform a differentiated automation layer in a workflow that is operationally painful and expensive for providers [EIN Presswire, 2026]. The loser if healthcare buyers prefer consolidated procurement over point automation is Serene Intelligence itself, because the public evidence does not yet show the scale, capital base, or independent channel control that would offset bundling pressure from larger platforms [Crunchbase, retrieved 2026] [chooseserene.com, retrieved 2024]. That does not negate the product thesis. It means the next competitive proof point needs to be distribution and adoption, not a broader set of workflow claims.
Company-stated, unverified -- This section relies heavily on company materials and one partnership announcement, with no confirmed named competitors or independent public evidence on customer adoption, funding depth, or market share.
Opportunity
PUBLIC
The prize here is large if Serene executes, because prior authorization, eligibility, claim status, and appeals sit inside recurring revenue-cycle workflows that providers already have to run, and the company is positioning itself inside the systems where that work actually happens rather than around the edges [chooseserene.com] [Crunchbase].
The headline opportunity is not simply to sell another workflow tool, but to become an operating layer for repetitive payer-facing work inside provider revenue cycle teams. That outcome is at least reachable on the public record because Serene is described as working across EHRs, payer portals, and internal systems, with tasks delegated from a dashboard or API and completed inside existing workflows [chooseserene.com]. Crunchbase separately describes the company as building healthcare workflow automation software that operates within payer portals and EHR environments, specifically across prior authorizations, appeals and denials, eligibility and benefits verification, and claim status retrieval [Crunchbase]. The Dyvine EHR partnership matters in that context: if Serene can be embedded directly into an EHR environment rather than sold only as a standalone overlay, distribution and retention dynamics improve materially [EIN Presswire, 2026].
That path still needs proof, but the shape of the opportunity is visible. Prior authorization and adjacent reimbursement tasks are mandatory work, not discretionary software usage, and Serene's own product framing centers on reducing hours of manual clicking and turning the workflow into a short human review with an audit trail preserved for oversight [chooseserene.com]. If that workflow performs reliably, the company could become part of the system of record for how provider teams interact with payers on a growing share of administrative transactions [chooseserene.com] [LinkedIn, retrieved 2026].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Embedded EHR channel | Serene becomes the default automation layer for prior auth and appeals inside third-party clinical or administrative software | The announced integration with PQT Health's Dyvine EHR platform extends distribution beyond direct sales [EIN Presswire, 2026] | Public sources already describe Serene's capabilities as being integrated into Dyvine EHR and delivered within that platform, which is a credible first step toward channel-led adoption [EIN Presswire, 2026] [LinkedIn, retrieved 2026] |
| RCM expansion play | A narrow wedge in prior authorization expands into adjacent claims, eligibility, and appeals workflows for the same provider customers | Cross-sell from one high-friction workflow into neighboring tasks handled by the same back-office teams [chooseserene.com] | The company already presents these functions as one workflow family rather than separate products, suggesting an expansion path from a single entry point to a broader administrative suite [chooseserene.com] [Crunchbase] |
| API and automation infrastructure | Serene shifts from task application to underlying execution layer used by provider operations teams and software partners | Use of the dashboard or API becomes a developer and operations entry point for broader automation [chooseserene.com] | The public product description explicitly says tasks can be delegated via dashboard or API and executed across EHRs and payer portals, which is consistent with an infrastructure-style product direction [chooseserene.com] |
The scenarios above point to the same compounding mechanism: each successfully automated workflow should make the next one easier to sell, deploy, and trust. Serene says it can be added to existing tools with login, permissions, and workflows, then execute work the same way a human team would while logging every action and outcome for review [chooseserene.com]. If that implementation model holds, the product benefits from a practical flywheel, where one completed use case establishes security posture, operational trust, and process mapping for adjacent use cases, while the audit trail lowers the adoption barrier for compliance-sensitive healthcare teams [chooseserene.com]. The Dyvine EHR integration is an early public signal that this flywheel could extend beyond direct deployments into embedded distribution, though the public record does not yet show scale [EIN Presswire, 2026].
The size of the win is harder to quantify from public data because no funding, revenue, or customer metrics are confirmed here, and no market-sizing source is in the record. Even so, the upside case can be framed conservatively: if Serene became a meaningful embedded automation layer for provider RCM workflows across EHR and payer interactions, it could support venture-scale outcomes because it would sit in recurring, high-frequency administrative processes rather than one-off analytics projects (scenario, not a forecast) [chooseserene.com] [Crunchbase]. The most credible public evidence for that upside is not a revenue figure but the scope of workflow coverage already claimed, from prior auth through appeals, and the existence of at least one announced EHR partnership that suggests the product can travel through third-party distribution rather than only founder-led sales [chooseserene.com] [EIN Presswire, 2026].
Company-stated, unverified -- This section relies materially on company website claims and a partnership announcement, with partial corroboration from Crunchbase and LinkedIn but no public customer, revenue, or market-size verification.
Sources
Public sources
[chooseserene.com, retrieved 2024] Serene Intelligence - Digital Employees for Healthcare RCM | https://www.chooseserene.com/
[Crunchbase] chooseserene.com - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/chooseserene-com
[EIN Presswire, 2026] PQT Health and Serene Intelligence Announce Strategic Partnership to bring AI-Powered Prior Authorization to Dyvine EHR® | https://www.einpresswire.com/article/905895427/pqt-health-and-serene-intelligence-announce-strategic-partnership-to-bring-ai-powered-prior-authorization-to-dyvine-ehr
[EIN Presswire] PQT Health and Serene Intelligence Announce Strategic Partnership to bring AI-Powered Prior Authorization to Dyvine EHR® | https://www.einnews.com/amp/pr_news/905895427/pqt-health-and-serene-intelligence-announce-strategic-partnership-to-bring-ai-powered-prior-authorization-to-dyvine-ehr
[LinkedIn, retrieved 2026] Serene Intelligence | https://www.linkedin.com/company/sereneintelligence
[BeBee, retrieved 2026] Member of the Board of Advisors - Serene Intelligence | BeBee | https://bebee.com/us/jobs/member-of-the-board-of-advisors-serene-intelligence--theirstack-669624029
[tennessean.com] PQT Health and Serene Intelligence Announce Strategic Partnership to bring AI-Powered Prior Authorization to Dyvine EHR® - The Tennessean | https://www.tennessean.com/press-release/story/169234/pqt-health-and-serene-intelligence-announce-strategic-partnership-to-bring-ai-powered-prior-authorization-to-dyvine-ehr/
Articles about Serene Intelligence
- Serene Intelligence Automates the Prior Authorization Grind — The startup's 'digital employees' aim to tackle the costly administrative friction that delays patient care and consumes clinical hours.